Replimune Group, Inc. (REPL)
$13.20-0.38%Close
SELLRECOVERY · day 6
Key stats
Short interest · FINRA settlement 2026-09-15
52-week IV5.1%–499.5%
- Market cap
- $1.1B
- Beta
- 0.94
- P/E (TTM)
- -4.21
- IV-%ile
- 15
- IV ATM
- 74.4%
- Short % float
- 29.35%
- Days to cover
- 11.1
- SI change
- -3.3%
- 1W
- -0.30%
- 1M
- -10.63%
- vs SPY 1W
- -2.22%
- vs SPY 1M
- -12.35%
Industry peers
FMP comparable companies · ranked by market cap
- IOVABUYIovance Biotherapeutics, Inc.$6.3BRECOVERYQ 8$14.15-0.31%
- MBXSELLMBX Biosciences, Inc. Common Stock$2.8BCRISISQ 39$58.54-4.18%
- VIRBUYVir Biotechnology, Inc.$2.0BRECOVERYQ 13$11.78-0.69%
- AVBPSELLArriVent BioPharma, Inc.$1.3BCRISISQ -5$28.46+11.93%
- MGTXSELLMeiraGTx Holdings plc$1.0BCRISISQ 7$10.92+2.08%
- DNABUYGinkgo Bioworks Holdings, Inc.$979MCRISISQ -17$14.98-7.57%
- ATXSAstria Therapeutics, Inc.$718M$12.58
- PRMEBUYPrime Medicine, Inc.$580MRECOVERYQ -6$3.21+11.43%
- VALNSELLValneva SE$551MCRISISQ -0$5.82+0.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 42
- GARP
- 1
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-95.6%
REV YoY-
ROE-44.1%
EPS YoY-
ROA-117.7%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-4.21
P/E FWD-
SECTOR PE20.33
INDUSTRY PE14.17
P/B12.15
P/FCF-
EV/EBITDA-3.57
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E105.99
ALTMAN Z-
CURR RATIO5.23
ND/EBITDA-
BETA0.94
NET INCOME (TTM) < 0
